175 related articles for article (PubMed ID: 26525042)
21. miR-92a regulates angiogenic activity of adipose-derived mesenchymal stromal cells.
Kalinina N; Klink G; Glukhanyuk E; Lopatina T; Efimenko A; Akopyan Z; Tkachuk V
Exp Cell Res; 2015 Nov; 339(1):61-6. PubMed ID: 26477824
[TBL] [Abstract][Full Text] [Related]
22. Transplantation of modified human adipose derived stromal cells expressing VEGF165 results in more efficient angiogenic response in ischemic skeletal muscle.
Shevchenko EK; Makarevich PI; Tsokolaeva ZI; Boldyreva MA; Sysoeva VY; Tkachuk VA; Parfyonova YV
J Transl Med; 2013 Jun; 11():138. PubMed ID: 23742074
[TBL] [Abstract][Full Text] [Related]
23. Conditioned medium derived from mesenchymal stem cells overexpressing HPV16 E6E7 dramatically improves ischemic limb.
Chang MC; Tsao CH; Huang WH; Chih-Hsueh Chen P; Hung SC
J Mol Cell Cardiol; 2014 Jul; 72():339-49. PubMed ID: 24786397
[TBL] [Abstract][Full Text] [Related]
24. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.
Rehman J; Traktuev D; Li J; Merfeld-Clauss S; Temm-Grove CJ; Bovenkerk JE; Pell CL; Johnstone BH; Considine RV; March KL
Circulation; 2004 Mar; 109(10):1292-8. PubMed ID: 14993122
[TBL] [Abstract][Full Text] [Related]
25. Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model.
Gowdak LH; Poliakova L; Li Z; Grove R; Lakatta EG; Talan M
J Vasc Surg; 2000 Aug; 32(2):343-52. PubMed ID: 10917995
[TBL] [Abstract][Full Text] [Related]
26. Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation.
Di Santo S; Yang Z; Wyler von Ballmoos M; Voelzmann J; Diehm N; Baumgartner I; Kalka C
PLoS One; 2009 May; 4(5):e5643. PubMed ID: 19479066
[TBL] [Abstract][Full Text] [Related]
27. Serum C-peptide level correlates with the course of muscle tissue healing in the rabbit model of critical limb ischemia.
Tauber Z; Cizkova K; Janikova M; Jurcikova J; Vitkova K; Pavliska L; Porubova L; Krauze A; Fernandez C; Jaluvka F; Spackova I; Lochman I; Prochazka M; Johnstone BH; Prochazka V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):132-140. PubMed ID: 30198519
[TBL] [Abstract][Full Text] [Related]
28. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.
Zhang M; Gao X; Bai SJ; Ye XM; Zhang J
Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.
Kuwahara G; Nishinakamura H; Kojima D; Tashiro T; Kodama S
J Vasc Surg; 2013 Apr; 57(4):1090-9. PubMed ID: 23219511
[TBL] [Abstract][Full Text] [Related]
30. A vascular endothelial growth factor activating transcription factor increases the endothelial progenitor cells population and induces therapeutic angiogenesis in a type 1 diabetic mouse with hindlimb ischemia.
Diao Y; Lian L; Guo L; Chen H; Chen Y; Song X; Li Y
Chin Med J (Engl); 2014; 127(20):3623-9. PubMed ID: 25316240
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy.
Morishita R; Nakamura S; Hayashi S; Taniyama Y; Moriguchi A; Nagano T; Taiji M; Noguchi H; Takeshita S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Hypertension; 1999 Jun; 33(6):1379-84. PubMed ID: 10373220
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.
Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM
Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799
[TBL] [Abstract][Full Text] [Related]
34. Secretomes from bone marrow-derived mesenchymal stromal cells enhance periodontal tissue regeneration.
Kawai T; Katagiri W; Osugi M; Sugimura Y; Hibi H; Ueda M
Cytotherapy; 2015 Apr; 17(4):369-81. PubMed ID: 25595330
[TBL] [Abstract][Full Text] [Related]
35. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.
Ledford KJ; Murphy N; Zeigler F; Bartel RL; Tubo R
Stem Cell Res Ther; 2015 Mar; 6(1):25. PubMed ID: 25889271
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal shock wave-assisted adipose-derived fresh stromal vascular fraction restores the blood flow of critical limb ischemia in rat.
Yin TC; Sung PH; Chen KH; Li YC; Luo CW; Huang CR; Sheu JJ; Chiang JY; Lee MS; Yip HK
Vascul Pharmacol; 2019 Feb; 113():57-69. PubMed ID: 30597218
[TBL] [Abstract][Full Text] [Related]
38. Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb.
Edwards BB; Fairman AS; Cohen JE; MacArthur JW; Goldstone AB; Woo JB; Hiesinger W; Woo YJ
J Vasc Surg; 2016 Oct; 64(4):1093-9. PubMed ID: 26372192
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic effect of human adipose-derived stromal cells cluster in rat hind-limb ischemia.
Park IS; Kang JA; Kang J; Rhie JW; Kim SH
Anat Rec (Hoboken); 2014 Dec; 297(12):2289-98. PubMed ID: 25066828
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
